Reimbursement News
Reimbursement news and insurance coverage updates.
UK's NICE Supports Keytruda With Chemo for PD-L1 Positive Esophageal Cancer Patients
The agency said the life-extending treatment would be cost-effective for NHS to provide as a first-line option for certain esophageal and gastro-esophageal junction cancers.
Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage
The next-generation sequencing-based tests can be performed on small samples, including needle aspiration samples, and use artificial intelligence software.
Roche, Canadian Organizations Launch Real-World Evidence Framework in British Columbia
The aim within the initiative is to generate and assess real-world evidence, and use the data to support reimbursement for precision oncology therapies.
The proposed change would delete payable cancer codes if they contain the word "unspecified" even if the word is included in a code that doesn't impact coverage.
Amid more tests, drugs, and emerging evidence, commercial insurance coverage for comprehensive genomic profiling remains inconsistent, contributing to access disparities.